$AMGN Triggered Lows NASDAQ:AMGN has alerted for a potential move lower. Target is set for 313.49. Will need some volume or wind from the market for this move.
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.10 EUR
6.09 B EUR
25.38 B EUR
536.26 M
About Amgen Inc.
Sector
Industry
CEO
Robert A. Bradway
Website
Headquarters
Thousand Oaks
Founded
1980
FIGI
BBG00J7BK058
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Amgen: False Breakdown and Uptrend?Amgen has been fighting higher this year, and some traders may think a longer-term uptrend is in place.
The first pattern on today’s chart is the move under $310 after mixed quarterly results. The drugmaker quickly recovered as Wall Street focused on its pipeline. The resulting drop and rebound cou
Long OP Motivation
Bear candle is rejected.
Company outlook is bullish.
Price/earning spiral looks to establish.
AMGN - Increased Probability of AppreciationAMGN has the support of Fiboclouds indicating an increased probability of appreciation at least until the first target. The second target should be tested, provided the stop loss is properly repositioned at the time of the first partial realization.
If this projection is confirmed and a partial rea
AMGN breaking above supply and fib levelThis good be a good risk vs reward. This stock has been acting nice breaking above recent highs and fib level. Also its sector seems to be for now breaking out.
Buyback Patterns for Swing TradingNASDAQ:AMGN shows a buyback run followed by a sell day that was instigated by market makers as buyers quickly disappeared. Remember that corporate buybacks are done by bank floor traders to add stock to their inventory so they won't take profits at the peak of the run; those are other market partic
AMGN Puts 290 Strike August 16th Expiration.I believe "AMGN" will get to around 217.7ish and then dip. From a technical viewpoint I believe its showing a "head and shoulders top" based on a chart that looks back since August of 2023. I am a rookie and don't know if this is true but am basing it on that. From a fundamental viewpoint I believe
Amgen's MariTide Shakes Up Weight Loss Drug MarketThe weight loss drug market, projected to hit $100 billion by the decade's end, is undergoing significant innovation. Amidst dominant players like Novo Nordisk and Eli Lilly, Amgen is emerging with MariTide, a potentially game-changing drug set to disrupt the industry. MariTide's extended-release fo
AMGN Rises as CEO Celebrates Growth in Experimental Obesity DrugAmgen Inc.'s shares ( NASDAQ:AMGN ) rose by 15.9% when the market opened on Friday, marking its biggest intraday rise since July 2009. The company has emerged as a potential competitor to Eli Lilly & Co. and Novo Nordisk A/S, which currently dominate the weight-loss market. Demand for anti-obesity d
AMGN potential buy setupReasons for bullish bias:
- Price bounced from support
- Weekly bullish candle closing at support
- 0.5 fib retracement
Entry Level (CMP): 278.40
Stop Loss Level: 264.03
Take Profit Level 1: 292.77
Take Profit Level 2: 307.14
Take Profit Level 3: Open
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where 1AMGN is featured.
Frequently Asked Questions
The current price of 1AMGN is 297.80 EUR — it has decreased by −1.54% in the past 24 hours. Watch AMGEN stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange AMGEN stocks are traded under the ticker 1AMGN.
1AMGN stock has risen by 0.53% compared to the previous week, the month change is a 2.74% rise, over the last year AMGEN has showed a 18.65% increase.
We've gathered analysts' opinions on AMGEN future price: according to them, 1AMGN price has a max estimate of 372.15 EUR and a min estimate of 183.78 EUR. Watch 1AMGN chart and read a more detailed AMGEN stock forecast: see what analysts think of AMGEN and suggest that you do with its stocks.
1AMGN reached its all-time high on Aug 1, 2024 with the price of 337.65 EUR, and its all-time low was 138.00 EUR and was reached on Mar 29, 2018. View more price dynamics on 1AMGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1AMGN stock is 1.57% volatile and has beta coefficient of 0.37. Track AMGEN stock price on the chart and check out the list of the most volatile stocks — is AMGEN there?
Today AMGEN has the market capitalization of 160.10 B, it has increased by 0.17% over the last week.
Yes, you can track AMGEN financials in yearly and quarterly reports right on TradingView.
AMGEN is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
1AMGN earnings for the last quarter are 5.01 EUR per share, whereas the estimation was 4.74 EUR resulting in a 5.79% surprise. The estimated earnings for the next quarter are 4.69 EUR per share. See more details about AMGEN earnings.
AMGEN revenue for the last quarter amounts to 7.64 B EUR, despite the estimated figure of 7.63 B EUR. In the next quarter, revenue is expected to reach 8.20 B EUR.
1AMGN net income for the last quarter is 2.54 B EUR, while the quarter before that showed 696.47 M EUR of net income which accounts for 264.95% change. Track more AMGEN financial stats to get the full picture.
Yes, 1AMGN dividends are paid quarterly. The last dividend per share was 2.04 EUR. As of today, Dividend Yield (TTM)% is 2.76%. Tracking AMGEN dividends might help you take more informed decisions.
AMGEN dividend yield was 2.96% in 2023, and payout ratio reached 68.24%. The year before the numbers were 2.95% and 64.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 8, 2024, the company has 26.70 K employees. See our rating of the largest employees — is AMGEN on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AMGEN EBITDA is 10.85 B EUR, and current EBITDA margin is 44.11%. See more stats in AMGEN financial statements.
Like other stocks, 1AMGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMGEN stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AMGEN technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AMGEN stock shows the buy signal. See more of AMGEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.